Login / Signup

Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery.

Kevin W McCoolEmmanuel SampeneBrock PolnaszekJoseph ConnorErin E MedlinLisa M Barroilhet
Published in: BMC cancer (2018)
Women undergoing neoadjuvant chemotherapy for ovarian cancer are at high risk of exposure to blood transfusion at the time of interval cytoreductive surgery. Future studies will continue to evaluate the safety and impact of transfusion on ovarian cancer survival in this at risk population.
Keyphrases